Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00290758 · ClinicalTrials.gov registry record · Phase 2
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
NCT00290758 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 126 participants.
The verdict
NCT00290758, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
Study Summary
This randomized phase II trial is studying how well genistein works in preventing breast cancer in women at high risk for breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of genistein may prevent breast cancer in women at high risk for breast cancer.
Interventions
- DRUG placebo
- OTHER laboratory biomarker analysis
- DRUG genistein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00290758
The ClinicalTrials.gov registry entry for NCT00290758 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00290758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00290758 about?
NCT00290758 is a clinical study titled "Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer". This randomized phase II trial is studying how well genistein works in preventing breast cancer in women at high risk for breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of genistein may prevent breast cancer in women at high r...
What is the current status of trial NCT00290758?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2006-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00290758?
The interventions under investigation include: placebo (DRUG), laboratory biomarker analysis (OTHER), genistein (DRUG).
Who is sponsoring clinical trial NCT00290758?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.